Competing interests
The authors disclose the following conflicts of interest related to this manuscript: SSP has received grants/contracts from Apellis, Genentech-Roche, Ionis, IVERIC bio, and Stealth, consulting fees from IVERIC bio and Genentech-Roche, and has participated on a data safety monitoring board or advisory board for IVERIC bio. DRL has received investigator grants from Annexon, Apellis, IVERIC bio, and Stealth, consultant fees from Annexon, Apellis, IVERIC bio, and Stealth, honoraria from Annexon, Apellis, IVERIC bio, and Stealth, travel support from Annexon, Apellis, IVERIC bio, and Stealth, and served on steering committees for Annexon and IVERIC bio. JH has received institutional research grants from Genetech-Roche and IVERIC bio, and consulting fees from Gyroscope and IVERIC bio. CCW’s research has been funded in part through grants or contracts from Annexon, Apellis, Genentech-Roche, Gyroscope, Ionis, IVERIC bio, and NGM, and has received consulting fees from Annexon, Apellis, Genentech-Roche, Gyroscope, IVERIC Bio, NGM, and Stealth. DE has received contracts or grants from Annexon, Genentech-Roche, Gyroscope, Ionis, IVERIC bio, and NGM, consulting fees from Apellis, Genentech-Roche, Gyroscope, and IVERIC bio, payment or honoraria from Apellis, Genentech-Roche, and has served on advisory boards for Genentech-Roche, IVERIC bio. JSH has received consulting fees from Allegro, Annexon, Apellis, Genentech-Roche, Gyroscope, IVERIC bio, NGM, Stealth, has participated on advisory boards for Annexon, Apellis, Genentech-Roche, Gyroscope, IVERIC bio, NGM, and holds stock/stock options in Allegro. GJJ has received institutional research grants or contracts from Annexon, Ionis, and Genentech-Roche, consulting fees from Genentech-Roche, and has participated on an advisory board for Annexon. KW, DD, and LZ are employees of IVERIC bio. AMK has received contracts or grants from Annexon, Apellis, Gyroscope, IVERIC bio, NGM, Genentech-Roche, consulting fees from Apellis, Genentech-Roche, Gyroscope, IVERIC bio, and Stealth, and honoraria from Apellis and Genentech-Roche.